IOVA
Iovance BiotherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
IOVA vs peer average
32/100
IOVA vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 4 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead, through Kite, is the closest commercial cell-therapy benchmark in the peer list; it is much larger, but it shows that manufacturing consistency and treatment-center execution can matter as much as efficacy after launch.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IOVA
Iovance Biotherapeutics
GILD
Gilead Sciences
Grade
D
C
Momentum
72
26
Value
41
65
Sentiment
31
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs GILD
IOVA / GILD
Grade Position
Below peers
IOVA vs. peer average (D vs. C)
32/100
Momentum
72
IOVAValue
41
GILDSentiment
31
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IOVA
GILD is the first peer returned for this comparison set.